Authors
Anne Marie Fosnacht, MPH, is a Sr. Clinical Research Associate at The Center for Brain Health at NorthShore University HealthSystem.
Advertisement
Advertisement
Trending on HCPLive
1
Asundexian Receives FDA Approval for Secondary Stroke Prevention
2
COMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression
3
Zabopegdutide Improves Fibrosis, MASH Resolution at 48 Weeks
4
Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials
5

